Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 1;37(5):480-485.
doi: 10.1097/MOG.0000000000000758.

The national institutes of health's approach to address research gaps in pancreatitis, diabetes and early detection of pancreatic cancer

Affiliations
Review

The national institutes of health's approach to address research gaps in pancreatitis, diabetes and early detection of pancreatic cancer

Jose Serrano et al. Curr Opin Gastroenterol. .

Abstract

Purpose of review: Diseases of the pancreas are a broad spectrum of conditions resulting from metabolic, inflammatory, and neoplastic processes (pancreatitis, pancreatogenic diabetes, and pancreatic cancers). Pancreatic diseases cause significant morbidity, mortality, and cost.

Recent findings: Research progress in diseases of the exocrine pancreas (chronic pancreatitis [CP], pancreatogenic diabetes mellitus, and pancreatic cancer) has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development.

Summary: Given the increasing incidence and prevalence of CP and its complications, high mortality rate, and associated healthcare cost, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize and manage CP and its sequelae and to understand the diabetes/pancreatic cancer association.The studies undertaken by the CPDPC are described in other articles in this journal's issue.

PubMed Disclaimer

References

    1. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update. Gastroenterology 2019; 156:254–272.e11.
    1. HCUPnet. Healthcare Cost and Utilization Project: Diagnoses—ICD-9-CM Codes (ICD9), Principal Diagnosis: 577.0 Acute Pancreatitis, 577.1 Chronic Pancreatitis 2014. Available at: https://hcupnet.ahrq.gov . Accessed September 21, 2017.
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2018; 68:7–30.
    1. Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015; 149:1731–1741.e3.
    1. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74:2913–2921.

Publication types

MeSH terms